Purchases and Sales Made in Q3 2024 in Aclaris Therapeutics, Inc. (ACRS)
This table provides information about the institutional ownership of Aclaris Therapeutics, Inc. (ACRS) during Q3 2024. The information is specifically focused on institutions that hold shares of Aclaris Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-144K- 69.79% |
$161K - $202K
|
62.4K
$237K
|
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-205K- 18.43% |
$230K - $287K
|
908K
$3.45M
|
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-252K- 75.31% |
$283K - $353K
|
82.7K
$314K
|
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-331K- 9.93% |
$371K - $464K
|
3.01M
$11.4M
|
|
|
Nov 13, 2024
Q3 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-393K- 75.56% |
$440K - $551K
|
127K
$483K
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-511K- 58.35% |
$572K - $715K
|
365K
$1.39M
|
|
|
Nov 14, 2024
Q3 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-615K- 67.1% |
$689K - $861K
|
302K
$1.15M
|
|
|
Nov 14, 2024
Q3 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-648K- 68.87% |
$726K - $907K
|
293K
$1.11M
|